跳至主要内容
临床试验/RBR-59phz5c
RBR-59phz5c招募中1 期

Treatment of Diabetic Macular Edema with Intravitreal Injection of Dexamethasone 2 mg/m

niversidade Federal de Pernambuco0 个研究点开始时间: 2023年6月28日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18Y 至 0(—)

入选标准

  • age 18 or older; diagnosis of diabetes mellitus; presence of clinically significant bilateral diabetic macular edema; best corrected visual acuity between 20/400 and 20/40; central macular thickness >= 300 µm, measured by spectral domain optical coherence tomography.

排除标准

  • Any treatment for diabetic macular edema in the past 4 months; Panretinal photocoagulation within the past 4 months; Any eye surgery performed within the past 4 months; History of pars plano vitrectomy; History of open-angle glaucoma or corticosteroid-induced elevated intraocular pressure requiring ocular antiglaucoma or antihypertensive treatment; Intraocular pressure >= 21 mmHg; History of allergy to any product used in the procedure; Presence of tractional retinal detachment

研究者

发起方
niversidade Federal de Pernambuco

相似试验

尚未招募
2 期
Treatment of Diabetic macular edema with intravitreal injection of antiangiogenic agents with or without DexamethasoneMacular EdemaC19.246.099Diabetes
RBR-7468j4qniversidade Federal de Pernambuco
进行中(未招募)
不适用
Tratamiento del edema de macula diabético clinicamente significativo con Ranibizumab (LUCENTIS) intravitreo. TREATMENT OF DIABETIC CLINICALLY SIGNIFICANT MACULAR EDEMA WITH INTRAVITREOUS RANIBIZUMAB (LUCENTIS)Edema de macula diabético refractario.REFRACTORY MACULAR EDEMA IN DIABETIC PATIENTS
EUCTR2008-006879-71-ESHOSPITAL SAN PEDRO
进行中(未招募)
1 期
Comparison of the efficacy of treatment of retinal macular inflammation due to diabetes with ozurdex or with ozurdex plus laser treatment in the area.Diabetic macular edemaMedDRA version: 19.0 Level: LLT Classification code 10057934 Term: Diabetic macular edema System Organ Class: 100000004853
EUCTR2016-003870-41-ESFundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias30
已完成
不适用
Intravitreal anti-VEGF Therapies for Macular Edema Folowing Retinal Vein OcclusioRetinal vein occlusion
JPRN-UMIN000023005Kawasaki Medical School33
进行中(未招募)
不适用
Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation: a Randomized, Double-Masked, Placebo-Controlled, Cross-over, 32 Weeks StudyDiabetic Macular OedemaMedDRA version: 8.1Level: LLTClassification code 10057915Term: Diabetic macular oedema
EUCTR2006-001182-41-GRAss.Prof. Petros Sfikakis